Elanco Announces USDA Approval of TruCan™ Ultra Lyme-L4, the First and Only 1/2 mL Combination Vaccine for Lyme and Leptospirosis for Dogs

Impact · against what's priced in

Elanco's USDA approval for TruCan Ultra Lyme-L4 provides a tangible growth catalyst by introducing a first-of-its-kind low-volume combination vaccine. The potential for increased volume is bolstered by the AAHA's shift to classifying leptospirosis as a core vaccine, broadening the addressable market.

ELAN+0.60

No priced-in read yet